Clin2
NCT07862621Likely a fitNot yet recruiting

Testing a new drug with two common medicines

Healthy

Treatments studied

This trial tests an investigational drug called MK-6916 in healthy volunteers to see how it interacts with two common medicines (midazolam and rosuvastatin). It helps understand how the body processes these drugs together.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
18 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be in good general health
  • Your body mass index (BMI) must be between 18 and 32
  • You cannot have a history of cancer
  • You must not have hepatitis B, hepatitis C, or HIV

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07743151Recruiting· Phase 1
Study of the drug MK-1406 in healthy participants

This trial is testing a new drug, MK-1406, in healthy volunteers to see how the body processes it. It helps researchers find the right dose and check for side effects before testing in patients.

Hollywood, Florida
NCT07785830Not yet recruiting· Phase 1
How a new drug affects a common cholesterol medicine

This study checks if a new investigational drug (MK-4646) changes how the body handles rosuvastatin, a common cholesterol-lowering medicine. It is for healthy people to see if the new drug is safe to take together.

South Miami, Florida
NCT07765498Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine, currently known by the code LY4355756, in healthy people to check its safety and how the body handles it. Your participation could help show if this medicine is safe enough to move into larger testing.

Dallas, Texas
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT06845839Recruiting· Phase 1
Testing a new drug in healthy volunteers

This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.

Fair Lawn, New Jersey
NCT07697625Recruiting· Phase 1
Study of MK-4082 in healthy volunteers

This trial tests a new medicine called MK-4082 in healthy people to see how safe it is and how the body handles it. It may help understand if the drug could be used for future treatments.

Anaheim, California

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.